Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease

Abstract

Background-This investigation compares the results of contemporary percutaneous coronary intervention (PCI) with standard balloon angioplasty among patients with multivessel coronary disease. By multivariate analysis, contemporary PCI was independently associated with reduced risk for in-hospital CABG, 1-year CABG, and 1-year PCI. Conclusions-Among patients with multivessel disease, contemporary PCI resulted in safer and more durable revascularization. These results support the role of PCI for selected patients with multivessel coronary artery disease.

Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001

“…Although CABG remains the recommended strategy for diabetic patients with multivessel CAD (41), recent advances in PCI (use of bare-metal and drug-eluting stents) have resulted in a changing paradigm for coronary revascularization procedures among patients with diabetes (19). The proportion of patients with diabetes who received PCI has increased (25.8%) compared with earlier percutaneous transluminal coronary angioplasty (balloon angioplasty) (13.4%) (42), which concord with the substantial increase in the use of PCI over time in the present large, observational study. The increase in revascularization use could have been the result of both increased capacity of the system and change in treatment.…”

Chronic Total Coronary Artery Occlusion Recanalisation with Percutaneous Coronary Intervention — Single Centre 10-Year Experience

“…For example, in Japanese centres CTO incidence was 19% and 61.2% of these cases were treated percutaneously (Yamamoto et al, 2013), however in North America, where CTOs are more frequent (29-33%), only between 6% and 9% of patients were treated percutaneously (Srinivas et al, 2002). In our study the percentage of CTO PCI procedures was low -only 6.2% of all PCI.…”

Coronary Revascularization in Diabetics: The Background for an Optimal Choice

“…This is clearly shown by the comparison between the diabetic patients in the 1985-1986 NHLBI PTCA registry and the contemporary patients in the 1997-2002 NHLBI Dynamic Registry (Srinivas 2002). Stenting was used in 87.5% of the latter registry and in none of the former, and resulted in greater angiographic success (94.8% versus 78.1%), less abrupt closure (0.9% versus 2.2%) and reduction of the hard end points of death (1.9% versus 4.3%), myocardial infarction (1.0% versus 7.4%), and in-hospital CABG surgery (0.8% versus 6.2%).…”